Article ; Online: An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review.
International immunopharmacology
2020 Volume 85, Page(s) 106654
Abstract: The present state of diagnostic and therapeutic developmental race for vaccines against the SARS CoV-2 (nCOVID-19) focuses on prevention and control of this global pandemic which also represents a critical challenge to the global health community. ... ...
| Abstract | The present state of diagnostic and therapeutic developmental race for vaccines against the SARS CoV-2 (nCOVID-19) focuses on prevention and control of this global pandemic which also represents a critical challenge to the global health community. Although development of novel vaccines can prevent the SARS CoV-2 infections, it is still impeded by several other factors and therefore novel approaches towards treatment and management of this disease is the urgent need. Passive immunotherapy plays a vital role as a possible alternative to meet this challenge and among various antibody sources, chicken egg yolk antibodies (IgY) can be used as an alternative to mammalian antibodies which have been previously studied against SARS CoV outbreak in China. In this review, we discuss the strategies for the use of chicken egg yolk (IgY) antibodies in the development of rapid diagnosis and immunotherapy against SARS CoV-2. Also, IgY antibodies have previously been used against various respiratory bacterial and viral infections in humans and animals. Compared to mammalian antibodies (IgG), chicken egg yolk antibodies (IgY) have greater binding affinity to specific antigens, ease of extraction and lower production costs, hence possessing remarkable pathogen-neutralizing activity of pathogens in respiratory and lungs. We provide an overall importance for the use of monoclonal chicken egg yolk antibodies (IgY) using phage display method describing their potential passive immunotherapeutic application for the treatment and prevention of SARS CoV-2 infection which is simple, fast and safe way of approach for treating patients effectively. |
|---|---|
| MeSH term(s) | Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Viral/immunology ; Antibody Affinity ; Antibody Specificity ; Betacoronavirus/genetics ; Betacoronavirus/immunology ; COVID-19 ; COVID-19 Testing ; Cell Surface Display Techniques ; Chickens ; Clinical Laboratory Techniques ; Coronavirus Infections/diagnosis ; Coronavirus Infections/therapy ; Egg Yolk ; Forecasting ; Humans ; Immunization, Passive ; Immunoglobulins/immunology ; Mammals/immunology ; Models, Molecular ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/therapy ; RNA, Viral/genetics ; SARS-CoV-2 ; Single-Chain Antibodies/immunology ; Species Specificity ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/metabolism ; COVID-19 Serotherapy |
| Chemical Substances | Antibodies, Monoclonal ; Antibodies, Viral ; IgY ; Immunoglobulins ; RNA, Viral ; Single-Chain Antibodies ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-06-03 |
| Publishing country | Netherlands |
| Document type | Journal Article ; Review |
| ZDB-ID | 2043785-7 |
| ISSN | 1878-1705 ; 1567-5769 |
| ISSN (online) | 1878-1705 |
| ISSN | 1567-5769 |
| DOI | 10.1016/j.intimp.2020.106654 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5408: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.